Letters to the Editor

Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation

Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
Chromosome Engineering Research Center, Tottori University, Tottori, Japan;
Chromosome Engineering Research Center, Tottori University, Tottori, Japan;
Perinatal Medical Center, Nagano Children's Hospital, Nagano, Japan;
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan;
Division of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan;
Division of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan;
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan;
Chromosome Engineering Research Center, Tottori University, Tottori, Japan;
Center for iPS cell Research and Application, Kyoto University, Kyoto, Japan
Dept. of Clinical Application, Center for iPS cell Research and Application, Kyoto University, Kyoto;
Vol. 106 No. 2 (2021): February, 2021 https://doi.org/10.3324/haematol.2019.242693